MicroVention is a rapidly growing medical device company who develops innovative neuroendovascular technologies for the treatment of vascular diseases in small vessels and is committed to developing and manufacturing the highest quality products for its customers and patients.   MicroVention products are sold through a direct sales force located in the U.S., Canada, France, Germany and the United Kingdom and through distributors in 50 other countries. In March 2006, Japanese-based Terumo® Corporation acquired MicroVention to enhance its multi-disciplinary holdings of medical device companies in North America.  Tokyo-based Terumo Corporation, is an international manufacturer and provider of general hospital, cardiac, vascular and home healthcare products.  For more than 80 years, the name Terumo has been synonymous with high-quality, innovative medical devices. From its start in 1921 as a manufacturer of clinical thermometers, Terumo Corporation has grown worldwide to a position of leadership in such areas as hollow-fiber technology, blood-management systems, and endovascular therapy. The high-quality medical products of Terumo Corporation are used in more than 160 countries and generate over $3 billion in global annual sales. MicroVention continues to lead the way in neuroendovascular therapies through their continued introduction of new and unique neurointerventional products including access products, intraluminal products and polymer coils, and is recognized on a global basis as a market leader and clinical innovator.  Today, with its commitment to developing and manufacturing the highest quality products for its customers and patients, MicroVention will continue to expand its product portfolio as it has historically and in the coming years. An estimated 50,000 patients in the United States are treated annually for cerebral aneurysms, with another 100,000 patients either undergoing surgery or endovascular treatment throughout the world. The MicroPlex Coil System and the HydroCoilEmbolization System are both designed for endovascular placement in a cerebral aneurysm to occlude the aneurysmal sac, thereby stabilizing and isolating the aneurysm from the neurovasculature. Specific benefits of these MicroVention technologies include:  -- Ability to treat wide neck aneurysms. -- Improved healing at the aneurysm neck. -- More complete filling of the aneurysm. -- Rapid thrombosis of the aneurysm. -- Minimal migration. -- Durable, long-term results. -- Safety and handling characteristics equivalent or superior to other existing products. Endovascular treatment of cerebral aneurysms offers numerous advantages over surgery, including less invasive access, reduced hospitalization and recovery time, reduced risk of infection, and substantially reduced overall cost. The HydroCoil (HES) and HydroSoft embolic coils combine a proprietary hydrogel polymer with a platinum helical coil. Once inserted, the hydrogel expands to provide additional filling and finishing of a vascular space. The MicroPlex Coil System (MCS) consists of a uniquely designed embolization device to include a three-dimensional framing coil, helical filling coils and the HyperSoft finishing coil for use in all types of aneurysm morphologies. The V-Trak Delivery System comprised of the Delivery Pusher and V-Grip Detachment Controller provides a more simplified operation and delivery for all MicroVention embolization coils. For more detailed information MicroVention Customer Service or to have your local MicroVention Representative or Distributor contact you at 714.247.8000 or 800-990-8368.